ArticleTrials2023

Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial.

Chae Won Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.